Stenocare grows, imports and distributes prescription-based medical cannabis oils.
Today, Stenocare operates in Denmark, Sweden, Norway, UK and Australia with 11 different prescription-based medical cannabis oil products for the treatment of pain and a variety of other conditions.
Stenocare works to ensure that doctors and patients can access a well-documented and pharmaceutical quality range of cannabis products. Stenocare operates in multiple countries, with a strong focus on providing prescription-based medical cannabis oils to patients.
Stenocare was the first Danish company to succeed in introducing prescription-based medical cannabis oil to Denmark, Sweden and Norway. The pharmaceutical products are monitored by the medicines agencies. Stenocare currently operates in Denmark, Sweden, Norway, UK and Australia and expects to have access to new markets in the coming years to enable more patients acquiring prescription-based medical cannabis.
Stenocare has received three permits from the Danish Medicines Agency to grow, handle and trade in narcotic substances as well as import and distribute medical cannabis in Denmark.
The Danish Medicines Agency controls and inspects companies that produce medicines – both before and after introduction to the market. The Danish Medicines Agency also controls companies that sell medicines. Only companies that have received written permission from the Danish Medicines Agency may produce and sell medicines in Denmark.
Cultivar Unknown
Further National Health-Service Information on